Skip to main content

Operator essays & forward calls

Perspectives

Short, sourced essays with a named forward call — written from the operator side of the bio-based economy and health & nutrition. The thinking behind the research and the advisory; free to read.
Cross-lens Jun 2026

The Bio-Based Economy Didn't Fail. The Drop-In Bet Did.

In 2004 the DOE named twelve building blocks to bio-base the chemical industry. Two decades on, not one had cleanly displaced a fossil incumbent. Here's the test that sorts the survivors — and what it means for the alt-protein and fermentation scale-ups struggling now.

Read →
Health & Nutrition Jun 2026

In Probiotics, the Best-Documented Strain Rarely Wins

Hundreds of evidenced strains sit unused while marketed strains with no strain-specific proof fill the shelf. What wins is the bundle — a consumer lane, a claim you may legally make, and a documented strain sourced into it.

Read →
Health & Nutrition Jun 2026

Infant Nutrition Is Gut Science's Frontier Lab — and the 'Just Give a Probiotic' Era Is Closing

The most advanced microbiome science on earth is run for the benefit of babies — the first 1,000 days are the frontier lab, and a leading indicator for adult health. Four days at the big paediatric gut-and-nutrition congress (ESPGHAN 2026), read as: where pre/pro/post-biotics, HMOs and bioactive metabolites are heading — and where the value migrates next.

Read →